Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 650x80px
Organisation › Details

Agennix (Group)

Agennix AG is a publicly listed biopharmaceutical company that is focused on the development of novel therapies that have the potential to substantially improve the length and quality of life of critically ill patients in areas of major unmet medical need. The Company's most advanced program is talactoferrin, a first-in-class oral Dendritic Cell Mediated Immunotherapy (DCMI). Talactoferrin is currently in Phase III clinical trials in non-small cell lung cancer. Other clinical development programs include RGB-286638, a multi-targeted kinase inhibitor in Phase I testing for cancer, and a topical gel form of talactoferrin for diabetic foot ulcers. Agennix's registered seat is in Heidelberg, Germany. The Company has three sites of operation: Planegg/Munich, Germany; Princeton, New Jersey and Houston, Texas. *

 

Period Start 1993-01-01 established
Period End 2013-05-31 dissolved
  Group HOPP Group (family of Dietmar Hopp)
  Predecessor GPC Biotech (Group)
Product Industry talactoferrin
     
Region Region Heidelberg
  Country Germany
  Street 515 Im Neuenheimer Feld
  City 69120 Heidelberg
    Address record changed: 2012-02-03
     
Basic data Employees B: 11 to 50 (2012-11-01)
     
    * Document for �About Section�: Agennix AG. (2/2/12). "Press Release: Agennix AG Halts Phase II/III OASIS Trial in Severe Sepsis". Planegg-Martinsried.
     
   
Record changed: 2017-04-01

Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 650x65px

More documents for HOPP Group (family of Dietmar Hopp)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px




» top